The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Infection Management in Hematology

Prevention and treatment of infections in neutropenic and immunosuppressed patients

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Infection Management in Hematology?

Infection management in hematology covers the prevention, diagnosis, and treatment of infections in patients with hematologic malignancies, bone marrow failure, and recipients of cellular therapies. It is one of the most important determinants of survival in modern hematologic care.

These patients face profound and prolonged immunosuppression from disease itself, intensive cytotoxic regimens, monoclonal antibodies, T-cell-depleting therapies, and graft-versus-host disease. Resulting risks include febrile neutropenia, invasive fungal disease, viral reactivation, and atypical bacterial infections.

Care is delivered through structured pathways that include screening, primary and secondary prophylaxis, environmental controls, prompt empiric broad-spectrum antibiotics for febrile neutropenia, and rapid de-escalation guided by cultures, molecular tests, and imaging.

Symptoms

Fever above 38 degrees during neutropenia
Chills, hypotension, or signs of sepsis
Cough, dyspnea, or new pulmonary infiltrates
Diarrhea, abdominal pain, or perianal infection
Skin lesions or central venous catheter site changes

Risk Factors

Acute leukemia and induction chemotherapy
Allogeneic stem cell transplantation
Graft-versus-host disease and prolonged corticosteroids
Use of fludarabine, anti-CD20, and anti-CD52 agents
Prolonged severe neutropenia and central venous catheters

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When fever or chills develop during chemotherapy
  • When new respiratory or gastrointestinal symptoms appear
  • When central catheter site shows redness or discharge
  • Before planned high-intensity therapy for prophylaxis review
  • When prior infections may reactivate during new immunosuppression

Treatment Methods

01
Risk-stratified prophylaxis against bacteria, fungi, and viruses
02
Prompt empiric broad-spectrum antibiotics for febrile neutropenia
03
Targeted antifungal therapy for invasive mold and yeast disease
04
Antiviral therapy for cytomegalovirus, herpes, and respiratory viruses
05
Monoclonal antibodies and granulocyte transfusions in selected cases
06
Catheter management and source control
07
De-escalation guided by molecular tests and antibiograms

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.